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We investigated whether computed tomography (CT) per-
fusion can identify intracerebral hemorrhage patients at
high risk of hematoma growth (HG). A total of 155 subjects
underwent CT perfusion on admission. Variables associated
with log-transformed absolute HGwere explored with mul-
tivariable linear regression. Perihematomal cerebral blood
volume (CBV) was inversely associated with HG (B = –0.20;
p < 0.001), independently from blood pressure, hematoma
volume, and other confounders. This association was not
dose dependent, and only very low CBV (<1.4 ml/100 g)
was significantly associated with HG (B = 0.25; p < 0.001).
In conclusion, reduced perihematomal CBV is associated
with HG, suggesting a potential role of the perihematomal
region in the pathophysiology of hematoma enlargement.
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Hematoma expansion is a common event in the natu-ral history of acute intracerebral hemorrhage (ICH)
and is independently associated with unfavorable progno-
sis.1 The pathophysiology of ICH expansion is complex
and controversial, and the role of the brain parenchyma
surrounding the hemorrhage remains unclear.2 One of the
hypothesis to explain hematoma growth is that active
bleeding continues until the counter pressure from the tis-
sue around the hemorrhage balances the pressure coming
from ruptured small vessels that started hemorrhage for-
mation.3 Following this model, reduced perfusion in the
perihematomal region may promote hemorrhage enlarge-
ment.4 In this computed tomography (CT) perfusion
(CTP)-based study we aimed at investigating whether
hypoperfusion in the perihematomal rim promotes ICH
expansion.
Materials and Methods
All aspects of this study received approval from the Institu-
tional Review Board of the Azienda Ospedaliera Universitaria,
Arcispedale S. Anna (Ferrara, Italy). Informed consent was
obtained from each patient or from close relatives before CTP
acquisition. Consecutive patients admitted at a single aca-
demic hospital for spontaneous ICH from January 2010 to
November 2015 were prospectively selected.5,6 We included
patients with age >18 years and diagnosis of supratentorial
ICHwithin 24 hours of symptom onset or time last seen well.
The main exclusion criteria were: (1) neoplastic or vascular
intracranial lesion presumed to be the source of the hemor-
rhage; (2) surgical treatment before follow-up noncontrast CT
(NCCT) scan; (3) unclear symptom onset; (4) pregnancy,
and (5) contraindication to the administration of iodinated
contrast material.
Clinical Variables
The following variables were collected: age, sex, history of hyperten-
sion, antiplatelet or anticoagulant treatment, admission systolic and
diastolic blood pressure (SBP and DBP), national institute of health
stroke scale (NIHSS), time from symptom onset to baseline NCCT,
andmodified Rankin Scale (mRS) at 3 months from the index event.
Image Acquisition and Analysis
All imaging was conducted on a 64-slice Lightspeed VCT scanner
(GE Healthcare, Waukesha, WI). ICH diagnosis was based on base-
line NCCT scan, obtained with axial technique with 5-mm slice
thickness. NCCT images were reviewed for determination of ICH
volume (ABC/2 method), ICH location (deep versus lobar), and
presence of intraventricular bleeding. All patients underwent a
follow-upNCCT scan at 24  6 hours from baseline NCCT or ear-
lier in case of neurological deterioration. ICH growth was analyzed as
a continuous variable (absolute hemorrhage volume increase from
baseline to follow-upNCCT) and as a dichotomous variable (hemor-
rhage volume increase >33% or >6 ml). CTP studies were performed
with a dynamic first-pass bolus-tracking methodology, according to a
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one-phase imaging protocol, and cerebral blood flow (CBF), cerebral
blood volume (CBV), andmean-transit-time (MTT)maps were gen-
erated using a commercially available delay-sensitive deconvolution
software, as described elsewhere.7 As previously reported,6 CBF,
CBV, and MTT maps were measured in four regions of interest
drawn freehand on every section in which the hematoma was visible:
(1) hemorrhagic core; (2) perihematomal rim; (3) 1-cm rim of
normal-appearing brain tissue surrounding the perilesional area; and
(4) a mirrored area, including the clot and the perihematomal region,
located in the contralateral hemisphere.
Statistical Analysis
Categorical variables are expressed as count (percentage) and were
compared with a χ2 test. Continuous variables were summarized as
median (interquartile range; IQR) or mean (standard deviation; SD)
as appropriate based on their normal versus non-normal distribution
evaluated with the Shapiro-Wilk test. Comparison between continu-
ous variables was performed with the Mann–WhitneyU test or t test,
as appropriate. Log-transformed absolute hematoma growth was the
main outcome of interest of the analysis. Univariable linear regression
was used to explore unadjusted associations between covariates and
hematoma growth. Variables associated with hematoma growth were
assessed with multivariable linear regression using a step-wise model
building method. The initial model included age, sex, covariates with
p < 0.10 in univariable analysis, and predictors of hemorrhage growth
identified from the literature such as time from onset to NCCT, ICH
volume, and anticoagulation.8 All these covariates were then backward
eliminated to a significance level of 0.10. Collinear factors were also
removed based on the variance inflation factor. In a secondary analysis,
ICH expansion is expressed as growth >33%or >6 ml. Variables asso-
ciated with ICH expansion were explored in a multivariable logistic
regression model, adjusting for ICH volume, anticoagulant treatment,
SBP and time from onset to NCCT.2 All the analyses were performed
with the statistical package, SPSS (version 21.0; www.spss.com), and
p values <0.05 were considered statistically significant.
Results
A total of 155 subjects met the inclusion criteria of the study
(median age, 68; 47.1% males; median ICH growth, 2 ml).
CBV and CBF values in the hemorrhagic core and peri-
hematomal rim were inversely associated with hemorrhage
growth in univariable analysis, as summarized in Table 1. After
adjustment for potential confounders, reduced perihematomal
CBVwas the only CTP variable independently associated with
increased hemorrhage growth, as shown in Table 2. The analy-
sis with perihematomal CBV stratified in quartiles showed that
hemorrhage growth was significantly higher in Q1 as com-
pared to all the other quartiles (Q1 versus Q2, B = 0.28,
p < 0.001; Q1 versus Q3, B = 0.21, p < 0.001; Q1 versus
Q4, B = 0.25, p < 0.001).
ICH volume, NIHSS and SBP were the other variables
associated with ICH growth. Secondary analyses confirmed
the inverse association between perihematomal CBV and risk
of ICH expansion after adjustment for ICH volume, NCCT
timing, anticoagulant treatment, and admission SBP (odds
ratio, 0.70; 95% confidence interval, 0.50–0.97; p = 0.033).
Figure 1 illustrates the predicted probability of ICH expansion
stratified by perihematomal CBV quartiles.
Discussion
To our knowledge, this is the first study exploring the relation-
ship between CTP values and ICH expansion. The inverse
association between perihematomal CBV levels and hema-
toma growth is the main finding of our analysis. This associa-
tion was not linear, and the odds of experiencing ICH
expansion increased only with CBV below a critical threshold.
In this setting, we found that perihematomal CBV with a cut-
off point <1.4 ml/100 g was the best CTP parameter to iden-
tify patients with ICH expansion. The biological mechanisms
explaining our findings remain unclear. Reduced CBV in the
perihematomal region may reflect the mass effect from the
hematoma, that is proportional to ICH volume.9 Another
possibility is that low CBV is a consequence of impaired cere-
bral perfusion pressure because of intensive SBP lowering.
However, when included together in the same regression
model, perihematomal CBV, ICH volume, and SBP were all
associated with ICH growth, independently from each other.
One possible explanation is that decreased CBV in the peri-
hematomal area promotes ICH growth because of a low pres-
sure counteracting the force of active bleeding from ruptured
small vessels.3 Another possibility may be that very low levels
of CBV lead to ischemia of small vessels surrounding the hem-
orrhage, promoting further vessel rupture that contribute to
hematoma enlargement.3,10 In our study, hematoma expan-
sion was associated with decreased perihematomal CBV rather
than CBF or MTT levels. This is indirectly in line with previ-
ous reports demonstrating that only reduced CBV and not
CBF or MTT values predicted hemorrhagic transformation in
patients with acute ischemic stroke,11,12 where it is widely
accepted that CTP can differentiate irreversibly damaged tis-
sue, the infarct core (characterized by low CBV and low CBF
but high MTT) from tissue at risk of infarction, the ischemic
penumbra (characterized by normal CBV and low CBF but
high MTT).13 This may suggest that reduced CBV reflects
the severity of hypoperfusion promoting endothelial injury
and blood–brain barrier impairment.12
Another interesting result was that CBV and SBP were
both independently associated with hematoma growth. SBP
reduction does not influence perihematoma perfusion,14 and
elevated SBP remains a plausible therapeutic target to limit
ICH growth. More studies are needed to explore the complex
and incompletely understood relationship between SBP and
cerebral perfusion in acute ICH.
Our results should be interpreted as preliminary and
hypothesis generating because of some important limitations.
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First, our findings were obtained from a relatively small cohort
collected at a single institution. The relatively small number of
patients with ICH expansion and the use of a step-wise model
building strategy raise the possibility of model overfit and
highlight the need for prospective confirmation of our find-
ings on a larger sample size. Second, many CTP acquisition
parameters may influence image quality, and there is no con-
sensus on the optimal CTP acquisition protocol, limiting the
TABLE 1. Cohort Characteristics and Univariable Linear Regression of Absolute Hematoma Growth
All (n = 155) B (SE) p
Age, median (IQR), y 68 (61–74) –0.02 (0.01) 0.815
Sex, male, n (%) 73 (47.1) 0.08 (0.07) 0.360
History of hypertension, n (%) 94 (60.6) 0.08 (0.10) 0.200
Antiplatelet treatment, n (%) 43 (27.7) 0.09 (0.06) 0.461
Anticoagulant treatment, n (%) 7 (4.5) 0.19 (0.15) 0.056
INR, median (IQR) 1.1 (1.0–1.2) 0.05 (0.16) 0.557
SBP, mean (SD), mm Hg 152 (28) 0.24 (0.002) 0.031
DBP, mean (SD), mm Hg 85 (14) –0.16 (0.004) 0.145
NIHSS, median (IQR) 14 (10–19) 0.55 (0.006) <0.001
Time from onset to NCCT, h 3.0 (2.2–3.5) 0.12 (0.04) 0.140
Baseline ICH volume, median (IQR) ml 12 (5–18) 0.51 (0.001) <0.001
ICH location, deep, n (%) 96 (61.9) –0.13 (0.09) 0.122
Presence of IVH, n (%) 37 (23.9) 0.30 (0.09) <0.001
Perihematoma edema, median (IQR), ml 20.2 (10.5–32.0) 0.60 (0.07) <0.001
Hematoma core
CBF, ml/100 g/min, median (IQR) 9,1 (6.0–13.4) –0.36 (0.14) <0.001
CBV, ml/100 g, median (IQR) 0.8 (0.5–1.1) –0.33 (0.18) <0.001
MTT, sec, median (IQR) 5.5 (4.1–6.8) 0.12 (0.24) 0.205
Perihematoma region
CBF, ml/100 g/min, median (IQR) 30.8 (21.1–47.2) –0.29 (0.002) <0.001
CBV, ml/100 g, median (IQR) 2.0 (1.4–3.0) –0.30 (0.04) <0.001
MTT, sec, median (IQR) 5.2 (4.5–6.6) 0.25 (0.03) 0.002
Normal appearing tissue
CBF, ml/100 g/min, median (IQR) 57.7 (43.2–79.6) –0.15 (0.18) 0.063
CBV, ml/100 g, median (IQR) 3.3 (2.5–4.1) –0.12 (0.21) 0.138
MTT, sec, median (IQR) 4.4 (3.6–5.1) 0.22 (0.32) 0.005
Absolute ICH growth, ml, median (IQR) 2 (1–5) n/a n/a
ICH expansion, n (%) 54 (34.8) n/a n/a
mRS >2 at 90 days, n (%) 55 (35.5) n/a n/a
ICH = intracerebral hemorrhage; INR = international normalized ratio; IQR = interquartile range; CBV = cerebral blood volume; CBF = cerebral
blood flow; MTT = mean transit time; IVH = intraventricular hemorrhage; mRS = modified Rankin Scale; NIHSS = National Institutes of Health
Stroke Scale; SBP = systolic blood pressure; DBP = diastolic blood pressure; n/a = not applicable; SE = standard error.
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generalizability of our results.15 Third, ICH volume measure-
ment with the ABC/2 method may be inaccurate, especially
compared to semiautomated analysis.16 Fourth, only admis-
sion SBP values were analyzed, and therefore we were not able
to further explore the interaction between perihematoma per-
fusion and blood pressure (BP) reduction. However, all
patients received the same BP treatment, according to the
American Heart Association/American Stroke Association
guidelines.17 Fifth, CTP may not be widely available, and it
remains to be determined whether this technique can improve
the stratification of ICH expansion risk compared with other
imaging markers.18 Sixth, the relationship between peri-
hematomal perfusion and imaging signs of ICH expansion,
such as the spot sign or NCCT markers, remain unclear.
Future studies should investigate whether perihematomal
CBV remains associated with ICH growth after adjustment
for these markers and also test whether the integration of dif-
ferent CTmodalities provides additional yield in the stratifica-
tion of ICH expansion risk.19 Finally, this is not a randomized
study, and the influence of unmeasured confounding factors
cannot be excluded. In conclusion, our results provide further
insights into the pathophysiology of ICH expansion, raising
the intriguing hypothesis that reduced CBV in the area sur-
rounding the hemorrhage may promote ICH growth. Further
studies appear warranted to characterize the biological mecha-
nisms mediating this association.
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TABLE 2. Multivariable Linear Regression of
Absolute ICH Growth
B (SE) p
ICH volume 0.61 (0.06) <0.001
Perihematoma CBV –0.20 (0.12) <0.001
NIHSS 0.19 (0.14) 0.001
SBP 0.11 (0.30) 0.019
B (SE) p
ICH volume 0.61 (0.06) <0.001
Perihematoma CBV quartiles
Q1 (<1.4 ml/100 g) 0.28 (0.15) <0.001
Q2 (1.4–2.0 ml/100 g) Reference
Q3 (2.1–3.0 ml/100 g) 0.07 (0.15) 0.232
Q4 (>3.0 ml/100 g) 0.03 (0.15) 0.602
NIHSS 0.20 (0.14) <0.001
SBP 0.11 (0.29) 0.017
B (SE) p
ICH volume 0.61 (0.06) <0.001
Perihematoma CBV quartiles
Q1 (<1.4 ml/100 g) 0.21 (0.15) <0.001
Q2 (1.4–2.0 ml/100 g) –0.07 (0.15) 0.232
Q3 (2.1–3.0 ml/100 g) Reference
Q4 (>3.0 ml/100 g) –0.04 (015) 0.527
NIHSS 0.20 (0.14) <0.001
SBP 0.11 (0.29) 0.017
B (SE) p
ICH volume 0.61 (0.06) <0.001
Perihematoma CBV quartiles
Q1 (<1.4 ml/100 g) 0.25 (0.16) <0.001
Q2 (1.4–2.0 ml/100 g) –0.03 (0.15) 0.602
Q3 (2.1–3.0 ml/100 g) 0.04 (0.15) 0.527
Q4 (>3.0 ml/100 g) Reference
NIHSS 0.20 (0.14) <0.001
SBP 0.11 (0.29) 0.017
ICH = intracerebral hemorrhage; CBV = cerebral blood volume;
NIHSS = National Institutes of Health Stroke Scale; SBP = systolic
blood pressure; SE = standard error.
FIGURE 1: Predicted probability of ICH expansion stratified
by perihematomal CBV quartiles. Q1, CBV <1.4 ml/100 g; Q2,
CBV 1.4 to 2.0 ml/100 g; Q3, 2.1 to 3.0 ml/100 g; Q4, CBV
(>3.0 ml/100 g). ICH expansion was defined as ICH growth
>33% or >6 ml, and every patient’s predicted probability of ICH
expansion was calculated using individual data and logistic
regression model estimates and is expressed as a continuous
variable ranging from 0 to 1. CBV = cerebral blood volume;
ICH = intracerebral hemorrhage.
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